The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Petrova G.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Kaprin A.D.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Starinskiĭ V.V.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdravsotsrazvitiia Rossii

Gretsova O.P.

FGBU "Moskovskiĭ nauchno-issledovatel'skiĭ onkologicheskiĭ institut im. P.A. Gertsena" Minzdrava Rossii

Incidence of malignant neoplasms in the population of Russia

Authors:

Petrova G.V., Kaprin A.D., Starinskiĭ V.V., Gretsova O.P.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2014;3(5): 5‑10

Read: 5326 times


To cite this article:

Petrova GV, Kaprin AD, Starinskiĭ VV, Gretsova OP. Incidence of malignant neoplasms in the population of Russia. P.A. Herzen Journal of Oncology. 2014;3(5):5‑10. (In Russ.)

Recommended articles:
Use of a new tetrapeptide analgesic at the stages of anti­tumor therapy. P.A. Herzen Journal of Onco­logy. 2024;(6):23-32
Oral cavity cancer epidemiology in men and women in the Sibe­rian Fede­ral District. Russian Journal of Preventive Medi­cine. 2024;(11):46-53
Cost of supportive cancer care in the Russian Fede­ration. Part 2. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):63-73
Approaches to the digi­tization of clinical guidelines. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):39-47

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.